The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 26, 2022
Filed:
Oct. 23, 2015
Applicant:
Setpoint Medical Corporation, Valencia, CA (US);
Inventors:
Jacob A. Levine, West Hempstead, NY (US);
Michael A. Faltys, Valencia, CA (US);
Assignee:
SetPoint Medical Corporation, Valencia, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61N 1/05 (2006.01); A61N 2/00 (2006.01); A61N 1/372 (2006.01); A61N 1/375 (2006.01); A61B 5/369 (2021.01); A61N 2/02 (2006.01); A61B 5/00 (2006.01); A61N 1/378 (2006.01); A61B 5/377 (2021.01);
U.S. Cl.
CPC ...
A61N 1/3606 (2013.01); A61B 5/369 (2021.01); A61N 1/0526 (2013.01); A61N 1/0529 (2013.01); A61N 1/0551 (2013.01); A61N 1/36053 (2013.01); A61N 1/36125 (2013.01); A61N 1/36135 (2013.01); A61N 1/36139 (2013.01); A61N 1/36146 (2013.01); A61N 1/3756 (2013.01); A61N 1/37205 (2013.01); A61N 2/006 (2013.01); A61B 5/377 (2021.01); A61B 5/4041 (2013.01); A61B 5/4064 (2013.01); A61N 1/0534 (2013.01); A61N 1/0556 (2013.01); A61N 1/3758 (2013.01); A61N 1/3787 (2013.01); A61N 1/37247 (2013.01); A61N 2/02 (2013.01);
Abstract
Described herein are methods and systems for using EEG recordings to improve vagus nerve stimulation (VNS) therapy. In particular, described herein are methods and systems for using EEG recordings to detect P300 and/or activation of the nucleus basalis and/or the locus coeruleus to determine the efficacy of VNS. The EEG recordings can be used to provide feedback control to help optimize stimulation parameters and to screen for patients that respond well to VNS therapy.